Thankfully, yes: GLP-1 hair loss is generally a temporary problem
Resource Free Peptide Research Ebook Become a member and receive your free copy of our exclusive Peptides eBook
Gene-editing therapy for neurological disease
A review of GLP-1 agonist studies using the standard dose in high intracranial pressure reported: Patients should be counseled about the high likelihood of nausea and GI upset (diarrhea, vomiting, and constipation, delayed gastric emptying) especially in the first 48 weeks of therapy
J Neurochem 137:714729 Tang S, Xu S, Lu X, Gullapalli RP, McKenna MC, Waddell J (2016) Neuroprotective effects of acetyl-l-carnitine on neonatal hypoxia ischemia-induced brain injury in rats
The Pros: Why the Wellness Market is Obsessed Unprecedented Targeted Healing: Peptides are made to target extremely particular biological pathways, in contrast to conventional broad-spectrum medications